The impact of inherited thrombophilia on surgery: A factor to consider before transplantation?

Molecular Biology Reports

Volumn 36, Issue 5, 2009, Pages 1041-1051

  Kfoury, Elias ^a   Taher, Ali ^a   Saghieh, Said ^a   Otrock, Zaher K ^a   Mahfouz, Rami ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Inherited; Screening; Surgery; Thrombophilia; Transplant

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ANTITHROMBIN DEFICIENCY; ARTICLE; AVASCULAR NECROSIS; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC DISORDER; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART SURGERY; HUMAN; HYPERCOAGULABILITY; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; LOW DRUG DOSE; ORTHOPEDIC SURGERY; PANCREAS TRANSPLANTATION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; THROMBOSIS PREVENTION; VASCULAR SURGERY; VENOUS THROMBOEMBOLISM;

ANIMALS; INHERITANCE PATTERNS; MASS SCREENING; SURGICAL PROCEDURES, OPERATIVE; THROMBOPHILIA; TRANSPLANTATION;

EID: 63949086585     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-008-9278-4     Document Type: Article

References (111)

1. Goldhaber SZ (1994) Epidemiology of pulmonary embolism and deep vein thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG (eds) Haemostasis and thrombosis. Churchill Livingstone, New York, p 1327
2. M Nordström B Lindblad D Bergqvist T Kjellström 1992 A prospective study of the incidence of deep-vein thrombosis within a defined urban population J Intern Med 232 155 160
3. FA Anderson HB Wheeler RJ Goldberg DW Hosmer NA Patwardhan B Jovanovic 1991 A population based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study Arch Intern Med 151 933 938 10.1001/archinte.151.5.933
4. ID Walker M Greaves 2001 On behalf of the haemostasis and thrombosis task force British committee for standards in haematology. Investigation and management of heritable thrombophilia Br J Haematol 114 512 528 10.1046/j.1365-2141.2001.02981.x
5. J Weitz S Middeldorp W Geerts JA Heit 2004 Thrombophilia and new anticoagulant drugs Hematology 20 424 438 10.1182/asheducation-2004.1.424
6. RH Thomas 2001 Hypercoagulability syndromes Arch Intern Med 161 2433 2439 10.1001/archinte.161.20.2433
7. J Voorberg J Roelse R Koopman H Büller F Berends JW ten Cate 1994 Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V Lancet 343 1535 10.1016/S0140-6736(94)92939-4
8. B Zoller J Holm P Svensson B Dahlbäck 1996 Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency Thromb Haemost 75 270
9. M Margaglione V Brancaccio N Giuliani G D'Andrea G Cappucci L Iannaccone 1998 Increased risk for venous thrombosis in carriers of prothrombin G A20210 gene variant Ann Intern Med 129 89 93
10. B Dahlback 2005 Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases J Intern Med 257 209 223 10.1111/j.1365-2796.2004.01444.x
11. E Olsson P Hoijer 2005 Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases Br J Plast Surg 58 720 723 10.1016/j.bjps.2004.12.024
12. U DeStefano P Chiusolo K Paciaroni G Leone 1998 Epidemiology of factor V Leiden: clinical implications Semin Thromb Hemost 24 367 379
13. PJ Svensson B Zoller I Mattiasson B Dahlbäck 1997 The factor V R506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis J Intern Med 241 379 385 10.1046/j.1365-2796.1997.124140000.x
14. DC Rees M Cox JB Clegg 1995 World distribution of factor V Leiden Lancet 346 1133 1134 10.1016/S0140-6736(95)91803-5
15. H Isma'eel R El Accaoui W Shamseddeen A Taher S Alam R Mahfouz 2006 Genetic thrombophilia in patients with VTE in eastern mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making? J Thromb Thrombolysis 21 267 270 10.1007/s11239-006-5537-1
16. RC Tait ID Walker PH Reitsma SI Islam F McCall SR Poort 1995 Prevalence of protein C deficiency in the healthy population Thromb Haemost 73 87 93
17. I Martinelli PM Mannucci V De Stefano E Taioli V Rossi F Crosti 1998 Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families Blood 92 2353 2358
18. U Seligsohn A Berger 1984 Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn N Engl J Med 310 559
19. R Bick 2003 Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects Hematol Oncol Clin North Am 17 9 36 10.1016/S0889-8588(02)00101-6
20. BJ Sanson P Simioni D Tormene M Moia PW Friederich MV Huisman 1999 On behalf of the TACT-study group. The incidence of venous thromboembolism in asymptomatic carriers of a marker of thrombophilia Blood 94 3702 3706
21. KH Gladson I Scharrer V Hach KH Beck JH Griffin 1988 The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis Thromb Haemost 59 18 22
22. K Brown R Luddington D Williamson P Baker T Baglin 1997 Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene Br J Haematol 98 907 909 10.1046/j.1365-2141.1997.3093130.x
23. SR Poort FR Rosendaal PH Reitsma RM Bertina 1996 A common genetic variant in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in thrombosis Blood 88 3698 3703
24. RC Tait ID Walker DJ Perry SI Islam ME Daly F McCall 1994 Prevalence of antithrombin deficiency in the healthy population Br J Haematol 87 106 112 10.1111/j.1365-2141.1994.tb04878.x
25. O Odegard U Abildgaard 1978 Antithrombin-III: critical review of assay methods. Significance of variations in health and disease Haemostasis 7 127 Abstract
26. RD Rosenberg 1975 Action and interaction of antithrombin and heparin N Engl J Med 292 146
27. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 111 113 10.1038/ng0595-111
28. PN Kirke JL Mills AS Whitehead A Molloy JM Scott 1996 Methylenetetrahydrofolate reductase mutation and neural tube defects Lancet 348 1037 1038 10.1016/S0140-6736(05)64971-9
29. R de Franchis G Sebastio C Mandato G Andria P Mastroiacovo 1995 Spina bifida, 677TC mutation and role of folate Lancet 346 1703 10.1016/S0140-6736(95) 92865-0
30. VR Arruda PM Von Zuben LC Chiaparini JM Annichino-Bizzacchi FF Costa 1997 The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis Thromb Haemost 77 818 821
31. M Klerk P Verhoef R Clarke HJ Blom FJ Kok EG Schouten MTHFR Studies Collaboration Group 2002 MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis JAMA 288 2023 2031 10.1001/jama.288.16.2023
32. ID Bezemer CJ Doggen HL Vos FR Rosendaal 2007 No association between the common MTHFR 677C-T polymorphism and venous thrombosis. Results from the MEGA study Arch Intern Med 167 497 501 10.1001/archinte.167.5.497
33. M Den Heijer FR Rosendaal HJ Blom WB Gerrits GM Bos 1998 Hyperhomocysteinemia and venous thrombosis: a meta-analysis Thromb Haemost 80 874 877
34. M Petri 2000 Epidemiology of the antiphospholipid syndrome J Autoimmun 15 145 151 10.1006/jaut.2000.0409
35. PE Love SA Santoro 1990 Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in SLE and in non-SLE disorders Ann Intern Med 112 682 698
36. R Cervera JC Piette J Font MA Khamashta Y Shoenfeld MT Camps Euro-Phospholipid Project Group 2002 Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 1019 1027 10.1002/art.10187
37. J Rand 2003 The antiphospholipid syndrome Annu Rev Med 54 409 424 10.1146/annurev.med.54.101601.152412
38. PW Kamphuisen JJ Houwing-Duistermaat HC van Houwelingen JC Eikenboom RM Bertina FR Rosendaal 1998 Familial clustering of factor VIII and von Willebrand factor levels Thromb Haemost 79 323 327
39. T Koster AD Blann E Briët JP Vandenbroucke FR Rosendaal 1995 Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 345 152 155 10.1016/S0140-6736(95)90166-3
40. KA Andreoni KL Brayman MK Guidinger CM Sommers RS Sung 2005 Kidney and pancreas transplantation in the United States, 1996-2005 Am J Transplant 7 1359 1375 10.1111/j.1600-6143.2006.01781.x
41. FR Green 2000 Genetic predisposition to thrombosis in renal transplant recipients: the factor V Q506 (Leiden) allele Transplantation 69 1547 1548 10.1097/00007890-200004270-00004
42. U John K Kentouche G Nowak J Schubert J Misselwitz 2006 Successful renal transplantation in a patient with heterozygous prothrombin gene, factor V Leiden mutation and heparin induced thrombocytopenia using r-hirudin Pediatr Transplant 10 114 118 10.1111/j.1399-3046.2005.00398.x
43. A Singh D Stablein A Tejani 1997 Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study Transplantation 63 1263 10.1097/00007890-199705150-00012
44. AJ Matas A Humar WD Payne KJ Gillingham DL Dunn DE Sutherland 1999 Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection Ann Surg 230 493 10.1097/00000658-199910000-00005
45. Y Vanrenterghem 1999 Vascular rejection with tacrolimus and potential long-term graft outcome Transplant Proc 31 86S 87S 10.1016/S0041-1345(99)00805-2
46. B Hocher T Slowinski I Hauser B Vetter L Fritsche D Bachert 2002 Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients Thromb Haemost 87 194 198
47. AB Irish FR Green 1997 Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients Nephrol Dial Transplant 12 167 10.1093/ndt/12.1.167
48. H Ekberg PJ Svensson M Simanaitis B Dahlbäck 2000 Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection Transplantation 69 1577 1581 10.1097/00007890-200004270-00010
49. M Fischereder P Gohring H Schneeberger P Lohse K Von Appen W Samtleben 1998 Early loss of renal transplants in patients with thrombophilia Transplantation 65 936 939 10.1097/00007890-199804150-00013
50. J Oh F Schaefer A Veldmann G Nowak U Nowak-Göttl B Tönshoff 1999 Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis Transplantation 68 575 578 10.1097/00007890-199908270-00022
51. S Heidenreich C Dercken C August HG Koch U Nowak-Göttl 1998 High rate of acute rejections in renal allograft recipients with thrombophilic risk factors J Am Soc Nephrol 9 1309
52. Y Ekmekci K Keven N Akar Y Egin S Sengul S Kutlay 2006 Thrombophilia and avascular necrosis of femoral head in kidney allograft recipients Nephrol Dial Transplant 21 3555 3558 10.1093/ndt/gfl400
53. M Fischereder H Schneeberger P Lohse BK Krämer D Schlöndorff W Land 2001 Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene Am J Kidney Dis 38 1061 1064 10.1053/ajkd.2001.28602
54. JP Forman J Lin M Pascual MD Denton N Tolkoff-Rubin 2004 Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation Am J Transplant 4 1786 1791 10.1046/j.1600-6143.2004.00602.x
55. VR Arruda WD Belangero MC Ozelo GB Oliveira RG Pagnano JB Volpon 1999 Inherited risk factor for thrombophilia among children with Legg-Calve-Perthes disease J Pediatr Orthop 19 84 87 10.1097/00004694-199901000-00019
56. AM Alkhunaizi AJ Olyaei JM Barry AM deMattos MJ Conlin MJ Lemmers 1998 Efficacy and safety of low molecular weight heparin in renal transplantation Transplantation 66 533 534 10.1097/00007890-199808270-00020
57. AJ Robertson V Nargund DW Gray PJ Morris 2000 Lowdose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients Nephrol Dial Transplant 15 1865 1868 10.1093/ndt/15.11.1865
58. GJ Murphy R Taha DC Windmill M Metcalfe ML Nicholson 2001 Influence of aspirin on early allograft thrombosis and chronic nephropathy following renal transplantation Br J Surg 88 261 266 10.1046/j.1365-2168.2001.01671.x
59. R Kandaswamy A Humar AC Gruessner JV Harmon DK Granger S Lynch 1999 Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine eras Transplant Proc 31 602 10.1016/S0041-1345(98)01574-7
60. JS Bynon RJ Stratta RJ Taylor JA Lowell M Cattral 1993 Vascular reconstruction in 105 consecutive pancreas transplants Transplant Proc 25 3288
61. HW Sollinger JS Odorico SJ Knechtle AM D'Alessandro M Kalayoglu JD Pirsch 1998 Experience with 500 simultaneous pancreas-kidney transplants Ann Surg 228 284 10.1097/00000658-199809000-00002
62. R Leggington JJ Olivero HE Adrogue V Ramanathan 2005 Recovery of allograft function after complete withdrawal of immunosuppression Transplant Proc 370 4380 4382 10.1016/j.transproceed.2005.10.027
63. GW Burke III G Ciancio J Figueiro R Buigas L Olson D Roth 2004 Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy Clin Transplant 18 423 428 10.1111/j.1399-0012.2004.00183.x
64. HE Adrogué AJ Matas RC McGlennon NS Key A Gruessner RW Gruessner 2007 Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? Clin Transplant 21 32 37 10.1111/j.1399-0012.2006.00574.x
65. J Andrassy M Zeier 2004 Do we need screening for thrombophilia prior to kidney transplantation? Nephrol Dial Transplant 19 64 68 10.1093/ndt/gfh1045
66. AGG Turpie MN Levine J Hirsh CJ Carter RM Jay PJ Powers 1986 A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery N Engl J Med 315 925 929
67. D Bergqvist 1992 Review of clinical trials of low molecular weight heparins. Clinical review Eur J Surg 158 67 68
68. R Collins A Scrimgeour S Yusuf R Peto 1988 Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin N Engl J Med 318 1162 1173
69. B Bergqvist G Benoni O Björgell H Fredin U Hedlundh S Nicolas 1996 Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement N Engl J Med 335 696 700 10.1056/NEJM199609053351002
70. ®) Thromb Haemost 77 26 31
71. A Planes N Vochelle JY Darmon M Fagola M Bellaud Y Huet 1996 Risk of deep venous thrombosis after hospital discharge in patients undergoing total hip replacement. Double-blind randomised comparison of enoxaparin versus placebo Lancet 348 224 228 10.1016/S0140-6736(96)01453-5
72. K Wåhlander G Larson TL Lindahl C Andersson L Frison D Gustafsson 2002 Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery Thromb Haemost 87 580 585
73. M Campos S Morais 2000 Absence of venous thromboembolism during orthopedic surgery in patients with FV Leiden mutation or 20210A allele of prothrombin gene Haemostasis 30 35 10.1159/000054155
74. DH Ryan MA Crowther JS Ginsberg CW Francis 1998 Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery Ann Intern Med 128 270 276
75. PJ Svensson G Benoni H Fredin O Björgell P Nilsson U Hedlund 1997 Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty Thromb Haemost 78 993 996
76. TL Lindahl TH Lundahl L Nilsson CA Andersson 1999 APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee-a prospective study Thromb Haemost 81 18 21
77. EA Salvati AG Della Valle GH Westrich AJ Rana L Specht BB Weksler 2005 The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty Clin Orthop Relat Res 441 40 55 10.1097/01.blo.0000192366.61616.81
78. BS Donahue 2004 Factor V Leiden and perioperative risk Anesth Analg 98 1623 1634 10.1213/01.ANE.0000113545.03192.FD
79. SA Ray MR Rowley A Loh SA Talbot DH Bevan RS Taylor 1994 Hypercoagulable states in patients with leg ischaemia BJS 81 811 814 10.1002/bjs.1800810607
80. PJ Svensson B Dahlbick 1994 Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 517 522 10.1056/NEJM199402243300801
81. MC Donaldson DS Weinberg M Belkin AD Whittemore JA Mannick 1990 Screening for hypercoagulable states in vascular surgical practice J Vasc Surg 11 825 831 10.1067/mva.1990.20120
82. S Vig A Chitolie S Sleight D Bevan J Dormandy MM Thompson 2004 Prevalence and risk of thrombophilia defects in vascular patients Eur J Vasc Endovasc Surg 28 124 131
83. LM Taylor Jr RW Chitwood RL Dalman G Sexton SH Goodnight JM Porter 1994 Antiphospholipid antibodies in vascular surgery patients: a cross-sectional study Ann Surg 220 544 551 10.1097/00000658-199410000-00012
84. RW Lee LM Taylor GJ Landry SH Goodnight GL Moneta JM Edwards 1996 Prospective comparison of infrainguinal bypass grafting in patients with and without Antiphospholipid antibodies J Vasc Surg 24 524 533 10.1016/S0741- 5214(96)70068-X
85. J Eldrup-Jorgensen D Flanigan DP Flanigan L Brace AP Sawchuk SG Mulder 1989 Hypercoagulable states and lower limb ischaemia in young adults J Vasc Surg 9 334 341 10.1067/mva.1989.vs0090334
86. SS Ahn K Kalunian M Rosove WS Moore 1988 Postoperative thrombotic complications in patients with the lupus anticoagulant: increased risk after vascular procedures J Vasc Surg 7 749 756 10.1067/mva.1988.avs0070749
87. CK Shortell K Ouriel RM Green JJ Condemi JA DeWeese 1992 Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis J Vasc Surg 15 158 166 10.1067/mva.1992.33164
88. S Nitecki B Brenner A Hoffman N Lanir A Schramek S Torem 1993 Lower limb ischaemia in primary antiphospholipid syndrome Eur J Vasc Endovasc Surg 7 414 419
89. G Collins RL Heymann R Zajtchuk 1975 Hypercoagulability in patients with peripheral vascular disease Am J Surg 130 2 6 10.1016/0002-9610(75)90444-4
90. WR Flinn MD McDaniel JS Yao VA Fahey D Green 1984 Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction J Vasc Surg 1 888 895 10.1067/mva.1984.avs0010888
91. K Ouriel RM Green JA DeWeese C Cimino 1996 Activated protein C resistance: prevalence and implications in peripheral vascular disease J Vasc Surg 23 46 57 10.1016/S0741-5214(05)80034-5
92. Y Berkun A Elami K Meir D Mevorach Y Naparstek 2004 Increased morbidity and mortality in patients with antiphopholipid syndrome undergoing valve replacement surgery J Thorac Cardiovasc Surg 127 414 420 10.1016/j.jtcvs.2003. 07.016
93. P Massoudy SM Cetin M Thielmann P Kienbaum JA Piotrowski G Marggraf 2005 Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder? Eur J Cardiothorac Surg 28 133 137 10.1016/j.ejcts.2004.12.062
94. R De Paulis G Bognolo F Tomai C Bassano M Tracey L Chiariello 1996 Early coronary artery bypass graft thrombosis in a patient with protein S deficiency Eur J Cardiothorac Surg 10 470 472 10.1016/S1010-7940(96)80119-9
95. S Schneider T Sakert J Lucke P McKeown A Sharma 2006 Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency Perfusion 21 117 120 10.1191/ 0267659106pf853oa
96. A Arboix S Bechich M Oliveres L García-Eroles J Massons C Targa 2001 Ischemic stroke of unusual cause: clinical features, etiology, and outcome Eur J Neurol 8 133 139 10.1046/j.1468-1331.2001.00180.x
97. M Ninomiya H Makuuchi T Ohtsuka S Takamoto 2001 Ischemic heart disease associated with protein C deficiency Eur J Cardiothorac Surg 20 883 885 10.1016/S1010-7940(01)00914-9
98. N Oysel J Bonnet C Vergnes D Benchimol MR Boisseau C Moreau P Bernadet E Baudet J Larrue H Bricaud 1989 Risk factors for myocardial infarction during coronary artery bypass graft surgery Eur Heart J 10 806 815
99. GM So MR Herbert EC Dooling F Buonanno BE Kosofsky D Ebb 1998 Multifocal embolic strokes following cardiac surgery in a protein C-deficient child J Child Neurol 13 629 631
100. ST Morozowich BS Donahue IJ Welsby 2006 Genetics of coagulation: considerations for cardiac surgery Semin Cardiothorac Vasc Anesth 10 297 313 10.1177/1089253206294345
101. PG Loubser JJ McCarthy M Attar 1997 Coronary thrombosis associated with antithrombin-III deficiency J Cardiothorac Vasc Anesth 11 756 759 10.1016/S1053-0770(97)90171-3
102. GJ Despotis G Gravlee K Filos J Levy 1999 Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques Anesthesiology 91 1122 1151 10.1097/00000542-199910000-00031
103. MS Avidan JH Levy H van Aken RO Feneck RD Latimer E Ott 2005 Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass J Thorac Cardiovasc Surg 130 107 113 10.1016/j.jtcvs.2004.10.045
104. JD Sweeney AJ Blair MP Dupuis TC King AL Moulton 1997 Aprotinin, cardiac surgery, and factor V Leiden Transfusion 37 1173 1178 10.1046/j.1537-2995.1997. 37111298088048.x
105. E Moor A Silveira F van't Hooft P Tornvall M Blombäck B Wiman 1998 Coagulation factor V (Arg506→Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting Thromb Haemost 80 220 224
106. IJ Welsby MV Podgoreanu B Phillips-Bute JP Mathew PK Smith MF Newman Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team 2005 Genetic factors contribute to bleeding after cardiac surgery J Thromb Haemost 3 1206 1212 10.1111/j.1538-7836.2005.01337.x
107. AJ Ravin RP Edwards A Krohn M Kelley Jr WA Christopherson JM Roberts 2002 The factor V Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients Obstet Gynecol 100 1285 1289 10.1016/S0029- 7844(02)02320-7
108. B Arnljots T Soderstrom H Svensson 1998 No correlation between activated protein C resistance and free flap failures in 100 consecutive patients Plast Reconstr Surg 101 1850 1853 10.1097/00006534-199806000-00011
109. MA Schusterman MJ Miller GP Reece SS Kroll M Marchi H Goepfert 1994 A single center's experience with 308 free flaps for repair of head and neck cancer defects Plast Reconstr Surg 93 472 478
110. DA Hidalgo CS Jones 1990 The role of emergent exploration in free-tissue transfer: a review of 150 consecutive cases Plast Reconstr Surg 86 492 498
111. C Ayala KE Blackwell 1999 Protein C deficiency in microvascular head and neck reconstruction Laryngoscope 109 259 265 10.1097/00005537-199902000-00016